title: Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.
authors.affiliation: Division of Rheumatology, Hospital Xeral Calde, Lugo, Spain. miguelaggay@hotmail.com
authors.forename: M A
authors.initials: MA
authors.lastname: Gonzalez-Gay
authors.forename: T R
authors.initials: TR
authors.lastname: Vazquez-Rodriguez
authors.forename: M T
authors.initials: MT
authors.lastname: Garcia-Unzueta
authors.forename: A
authors.initials: A
authors.lastname: Berja
authors.forename: J A
authors.initials: JA
authors.lastname: Miranda-Filloy
authors.forename: J M
authors.initials: JM
authors.lastname: de Matias
authors.forename: C
authors.initials: C
authors.lastname: Gonzalez-Juanatey
authors.forename: J
authors.initials: J
authors.lastname: Llorca